Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia
Sponsor
Ono Pharmaceutical Co. Ltd (Industry)
Overall Status
Completed
CT.gov ID
NCT00417326
Collaborator
(none)
174
9
2
19.3
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
174 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure
Study Start Date
:
Dec 1, 2006
Actual Primary Completion Date
:
Aug 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: P
|
Drug: ONO-5046Na
twenty four hour infusion at 0 mg/kg/hr for 14 days
|
Experimental: E
|
Drug: ONO-5046Na
twenty four hour intravenous infusion at 0.2 mg/kg/hr for 14 days
|
Outcome Measures
Primary Outcome Measures
- pulmonary function [14 days]
Secondary Outcome Measures
- mortality [28 days]
- ventilator status [28 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with community-acquired pneumonia
-
Patients with acute respiratory failure
Exclusion Criteria:
-
Patients with nosocomial pneumonia
-
Patients on mechanical ventilation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Chubu Region | Chubu | Japan | ||
2 | Chugoku Region | Chugoku | Japan | ||
3 | Hokkaido Region | Hokkaido | Japan | ||
4 | Hokuriku Region | Hokuriku | Japan | ||
5 | Kanto Region | Kanto | Japan | ||
6 | Kinki Region | Kinki | Japan | ||
7 | Kyushu Region | Kyushu | Japan | ||
8 | Shikoku Region | Shikoku | Japan | ||
9 | Tohoku Region | Tohuku | Japan |
Sponsors and Collaborators
- Ono Pharmaceutical Co. Ltd
Investigators
- Study Director: Koji Takehara, Ono Pharmaceutical Co. Ltd
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ono Pharmaceutical Co. Ltd
ClinicalTrials.gov Identifier:
NCT00417326
Other Study ID Numbers:
- ONO-5046Na-14
First Posted:
Jan 1, 2007
Last Update Posted:
Jun 13, 2012
Last Verified:
Jun 1, 2012
Keywords provided by Ono Pharmaceutical Co. Ltd
Additional relevant MeSH terms: